Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002023658-25-000073
Filing Date
2025-06-10
Accepted
2025-06-10 16:26:32
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749587186.html 4  
1 FORM 4 wk-form4_1749587186.xml 4 4044
  Complete submission text file 0002023658-25-000073.txt   5431
Mailing Address 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Bowden Christopher (Reporting) CIK: 0001608601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 251037463

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)